Ep 48: Time to Treatment Accelerating the Connection to Care

Pharma Isn't Broken — Access Is ixlayer x Sanofi Ventures @ HLTH 2025 Patients don't suffer because we lack medical innovation — they suffer because it takes too long to access it.  🚀 Why This Matters Patients today are consumers — they expect speed, personalization, and access. Pharma, technology, and venture capital are aligning to deliver it. The future of healthcare is collaborative, data-driven, and patient-first. Live from HLTH 2025 in the Diagnostic Zone, we dig into the real barriers between patients and lifesaving therapies. This episode covers:  How digital platforms reduce barriers to treatment How AI is fueling proactive, personalized care Why strategic capital accelerates patient-impact innovation Featuring: Pouria Sanae — Co-Founder & CEO, ixlayer Cris De Luca — Sanofi Ventures ⏱️ Timestamps  00:00 — Live at HLTH: Rethinking the pharma-patient connection 02:18 — Why patient access is the real bottleneck 04:20 — Sanofi Ventures: inside the strategic innovation model 06:45 — The truth about time-to-treatment in America 08:40 — The evolution of ixlayer & diagnostics infrastructure 10:30 — Can big pharma really go patient-first? 12:00 — Evidence, outcomes & trust in AI + health tech   Listen & Subscribe Never miss an episode where we challenge the status quo in healthcare and spotlight the innovators building what's next. Healing Healthcare™ starts with bold ideas — and the courage to build them.  #healthcareinnovation #digitalhealth #patientaccess #boombostichealth #aiinhealthcare #healthtech #pharmainnovation #futureofhealthcare #hlth2025 #hlthusa #PrecisionMedicine